261 related articles for article (PubMed ID: 31661569)
21. Epidemiology and outcomes of invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients in the era of antifungal prophylaxis: a single-centre study with focus on emerging pathogens.
Corzo-León DE; Satlin MJ; Soave R; Shore TB; Schuetz AN; Jacobs SE; Walsh TJ
Mycoses; 2015 Jun; 58(6):325-36. PubMed ID: 25808822
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology of invasive fungal diseases in children with solid tumours undergoing autologous haematopoietic stem cell transplantation: a 10-year experience in a tertiary Italian centre.
Tatarelli P; Faraci M; Caviglia I; Bandettini R; Cangemi G; Magnano GM; Garaventa A; Viscoli C; Castagnola E
Mycoses; 2017 Aug; 60(8):517-520. PubMed ID: 28429862
[TBL] [Abstract][Full Text] [Related]
23. Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation.
Groll AH; Castagnola E; Cesaro S; Dalle JH; Engelhard D; Hope W; Roilides E; Styczynski J; Warris A; Lehrnbecher T; ; ; ; ;
Lancet Oncol; 2014 Jul; 15(8):e327-40. PubMed ID: 24988936
[TBL] [Abstract][Full Text] [Related]
24. Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort study.
Kuster S; Stampf S; Gerber B; Baettig V; Weisser M; Gerull S; Medinger M; Passweg J; Schanz U; Garzoni C; Berger C; Chalandon Y; Mueller NJ; van Delden C; Neofytos D; Khanna N;
Transpl Infect Dis; 2018 Dec; 20(6):e12981. PubMed ID: 30144374
[TBL] [Abstract][Full Text] [Related]
25. Secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients with invasive fungal infection.
Pepeler MS; Yildiz Ş; Yegin ZA; Özkurt ZN; Tunçcan ÖG; Erbaş G; Köktürk N; Kalkanci A; Yildirim Z
J Infect Dev Ctries; 2018 Sep; 12(9):799-805. PubMed ID: 31999640
[TBL] [Abstract][Full Text] [Related]
26. Invasive fungal disease is associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplant: a single center, retrospective study.
Jin H; Fan Z; Huang F; Chai Y; Xuan L; Lin R; Xu N; Ye J; Sun J; Liu Q
Infection; 2019 Apr; 47(2):275-284. PubMed ID: 30734248
[TBL] [Abstract][Full Text] [Related]
27. Reduction in incidence of invasive fungal infection in patients receiving allogeneic stem cell transplantation using combined diagnostic-driven approach and itraconazole oral solution.
Tzadok R; Shapira MY; Moses AE; Or R; Block C; Strahilevitz J
Mycoses; 2015 Dec; 58(12):694-8. PubMed ID: 26429354
[TBL] [Abstract][Full Text] [Related]
28. Feasibility and effectiveness of posaconazole prophylaxis in combination with micafungin bridging for patients undergoing allogeneic stem cell transplantation: a 6-yr analysis from the cologne cohort for neutropenic patients.
Vehreschild MJ; von Bergwelt-Baildon M; Tran L; Shimabukuro-Vornhagen A; Wisplinghoff H; Bangard C; Cornely OA; Vehreschild JJ
Eur J Haematol; 2014 Nov; 93(5):400-6. PubMed ID: 24798021
[TBL] [Abstract][Full Text] [Related]
29. A Randomized Trial of Caspofungin vs Triazoles Prophylaxis for Invasive Fungal Disease in Pediatric Allogeneic Hematopoietic Cell Transplant.
Dvorak CC; Fisher BT; Esbenshade AJ; Nieder ML; Alexander S; Steinbach WJ; Dang H; Villaluna D; Chen L; Skeens M; Zaoutis TE; Sung L
J Pediatric Infect Dis Soc; 2021 Apr; 10(4):417-425. PubMed ID: 33136159
[TBL] [Abstract][Full Text] [Related]
30. Validation of a multivariable prediction model for post-engraftment invasive fungal disease in 465 adult allogeneic hematopoietic stem cell transplant recipients.
Rodríguez-Veiga R; Montesinos P; García E; Boluda B; Rojas R; Serrano J; Martínez-Cuadrón D; Martín C; Sanz J; Tabares S; Piñana JL; Lorenzo I; Montoro J; Salavert M; Pemán J; Jarque I; Solves P; Sanz GF; Torres A; Sanz MA
Mycoses; 2019 May; 62(5):418-427. PubMed ID: 30633829
[TBL] [Abstract][Full Text] [Related]
31. Antifungal chemoprophylaxis in children and adolescents with haematological malignancies and following allogeneic haematopoietic stem cell transplantation: review of the literature and options for clinical practice.
Tragiannidis A; Dokos C; Lehrnbecher T; Groll AH
Drugs; 2012 Mar; 72(5):685-704. PubMed ID: 22413762
[TBL] [Abstract][Full Text] [Related]
32. Long-Lasting Protective Effect of Posaconazole Prophylaxis in Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Stem Cell Transplantation.
Busca A; Candoni A; Audisio E; Passera R; Bruno B; Monaco F; Mordini N; Vacca A; Delia M; Aversa F; Pagano L
Biol Blood Marrow Transplant; 2016 Dec; 22(12):2214-2219. PubMed ID: 27667012
[TBL] [Abstract][Full Text] [Related]
33. Clinical and pharmacoeconomic evaluation of antifungal prophylaxis with continuous micafungin in patients undergoing allogeneic stem cell transplantation: A six-year cohort analysis.
Wingen-Heimann SM; Cornely OA; Vehreschild MJGT; Wisplinghoff H; Franke B; Schons M; von Bergwelt-Baildon M; Scheid C; Vehreschild JJ
Mycoses; 2021 Apr; 64(4):437-444. PubMed ID: 33354800
[TBL] [Abstract][Full Text] [Related]
34. Posaconazole oral suspension for secondary antifungal prophylaxis in allogeneic stem cell transplantation recipients: a retrospective study.
Ye P; Pei R; Hu Y; Chen D; Li S; Cao J; Li F; Wu M; Fang Y; Lu Y
BMC Infect Dis; 2022 May; 22(1):465. PubMed ID: 35570276
[TBL] [Abstract][Full Text] [Related]
35. Incidence, risk factors, and outcome of pulmonary invasive fungal disease after respiratory virus infection in allogeneic hematopoietic stem cell transplantation recipients.
Piñana JL; Gómez MD; Montoro J; Lorenzo I; Pérez A; Giménez E; González-Barberá EM; Carretero C; Guerreiro M; Salavert M; Sanz G; Hernández-Boluda JC; Borrás R; Sanz J; Solano C; Navarro D
Transpl Infect Dis; 2019 Oct; 21(5):e13158. PubMed ID: 31402532
[TBL] [Abstract][Full Text] [Related]
36. Sequential low-dose CT thorax scans to determine invasive pulmonary fungal infection incidence after allogeneic hematopoietic cell transplantation.
Enger K; Tonnar X; Kotter E; Bertz H
Ann Hematol; 2023 Feb; 102(2):413-420. PubMed ID: 36460795
[TBL] [Abstract][Full Text] [Related]
37. Invasive Fungal Disease Among Pediatric and Adolescent Patients Undergoing Itraconazole Prophylaxis After Hematopoietic Stem Cell Transplantation.
Itsaradisaikul S; Pakakasama S; Boonsathorn S; Techasaensiri C; Rattanasiri S; Apiwattanakul N
Transplant Proc; 2021; 53(6):2021-2028. PubMed ID: 33994183
[TBL] [Abstract][Full Text] [Related]
38. The clinical management of invasive mold infection in children with cancer or undergoing hematopoietic stem cell transplantation.
Lehrnbecher T
Expert Rev Anti Infect Ther; 2019 Jul; 17(7):489-499. PubMed ID: 31149864
[No Abstract] [Full Text] [Related]
39. Antifungal agents for secondary prophylaxis based on response to initial antifungal therapy in allogeneic hematopoietic stem cell transplant recipients with prior pulmonary aspergillosis.
Liu Q; Lin R; Sun J; Xiao Y; Nie D; Zhang Y; Huang F; Fan Z; Zhou H; Jiang Q; Zhang F; Zhai X; Xu D; Wei Y; Song J; Li Y; Feng R
Biol Blood Marrow Transplant; 2014 Aug; 20(8):1198-203. PubMed ID: 24769013
[TBL] [Abstract][Full Text] [Related]
40. Invasive Fungal Infections in Immunocompromised Children: Novel Insight Following a National Study.
Olivier-Gougenheim L; Rama N; Dupont D; Saultier P; Leverger G; AbouChahla W; Paillard C; Gandemer V; Theron A; Freycon C; Pluchart C; Blouin P; Pellier I; Thouvenin-Doulet S; Desplantes C; Ducassou S; Oudot C; Rouger-Gaudichon J; Cheikh N; Poiree M; Schneider P; Plat G; Contet A; Rialland F; Gouache E; Brethon B; Bertrand Y; Domenech C
J Pediatr; 2021 Sep; 236():204-210. PubMed ID: 33991540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]